03/12/2025
3:53 PM | Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:14 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:16 PM | Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:10 PM | Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:29 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
4:00 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:33 PM | Amphastar Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
6:21 PM | Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
| Form SCHEDULE 13G/A | |
12/16/2024
4:22 PM | Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:28 PM | Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
10:37 AM | Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for AMPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/13/2024
7:26 PM | Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
5:55 PM | Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
7:05 PM | Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
12:29 PM | Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
12:29 PM | Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
6:02 PM | Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:09 PM | Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
6:48 PM | Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:48 PM | Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:14 PM | Amphastar Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
8:33 PM | Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:26 PM | Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
4:58 PM | Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:25 PM | Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:15 PM | Amphastar Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:22 PM | Amphastar Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
3:32 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
4:24 PM | Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
3:26 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:25 PM | Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
5:35 PM | Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:32 PM | Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:51 PM | Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
7:10 PM | Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:54 PM | Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:56 PM | Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:03 PM | Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:56 PM | Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:58 PM | Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:00 PM | Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your Wealth is Under Attack (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today |
06/04/2024
3:14 PM | Amphastar Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
5:26 PM | Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:56 PM | Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:21 PM | Amphastar Pharmaceuticals (Filer)
| Form DEFA14A | |
04/12/2024
3:08 PM | Amphastar Pharmaceuticals (Filer)
| Form DEF 14A | |
04/12/2024
3:08 PM | Amphastar Pharmaceuticals (Filer)
| Form DEF 14A | |
04/12/2024
3:14 PM | Amphastar Pharmaceuticals (Filer)
| Form DEFA14A | |
04/12/2024
3:14 PM | Amphastar Pharmaceuticals (Filer)
| Form DEFA14A | |
04/02/2024
8:31 PM | Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:55 PM | Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
